Sunil V Rao

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. doi request reprint An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry
    Sunil V Rao
    Duke Clinical Research Institute, Durham, North Carolina Electronic address
    JACC Cardiovasc Interv 6:897-904. 2013
  2. doi request reprint Temporal trends in percutaneous coronary intervention outcomes among older patients in the United States
    Sunil V Rao
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 166:273-281.e4. 2013
  3. doi request reprint Clinical update: Remaining challenges and opportunities for improvement in percutaneous transradial coronary procedures
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, NC, USA
    Eur Heart J 33:2521-6. 2012
  4. doi request reprint Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients
    Sunil V Rao
    Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    JACC Cardiovasc Interv 5:958-65. 2012
  5. doi request reprint Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group
    Sunil V Rao
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 158:881-886.e1. 2009
  6. ncbi request reprint On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])
    Sunil V Rao
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 97:1478-81. 2006
  7. ncbi request reprint Clinical outcomes with drug-eluting stents following atheroablation therapies
    Sunil V Rao
    Durham Veterans Affairs Medical Center and the Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    J Invasive Cardiol 18:393-6. 2006
  8. doi request reprint Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients
    Sunil V Rao
    Duke Clinical Research Institute, 508 Fulton St, Durham, North Carolina, USA
    JAMA 306:1461-7. 2011
  9. doi request reprint Strategies to reduce bleeding among patients with ischemic heart disease treated with antiplatelet therapies
    Sunil V Rao
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Am J Cardiol 104:60C-3C. 2009
  10. ncbi request reprint Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, NC, USA
    Eur Heart J 28:1193-204. 2007

Collaborators

Detail Information

Publications77

  1. doi request reprint An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry
    Sunil V Rao
    Duke Clinical Research Institute, Durham, North Carolina Electronic address
    JACC Cardiovasc Interv 6:897-904. 2013
    ..This study sought to develop a model that predicts bleeding complications using an expanded bleeding definition among patients undergoing percutaneous coronary intervention (PCI) in contemporary clinical practice...
  2. doi request reprint Temporal trends in percutaneous coronary intervention outcomes among older patients in the United States
    Sunil V Rao
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 166:273-281.e4. 2013
    ..New percutaneous coronary intervention (PCI) device technologies are often rapidly adopted into clinical practice, yet few studies have examined the overall impact of these new technologies on patient outcomes in community practice...
  3. doi request reprint Clinical update: Remaining challenges and opportunities for improvement in percutaneous transradial coronary procedures
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, NC, USA
    Eur Heart J 33:2521-6. 2012
    ..In addition, a protocol for femoral bailout should be considered to maintain door-to-reperfusion metrics...
  4. doi request reprint Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients
    Sunil V Rao
    Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    JACC Cardiovasc Interv 5:958-65. 2012
    ..The authors sought to describe the association between post-procedural bleeding and long-term recurrent bleeding, major adverse cardiac events (MACE), and mortality among older patients undergoing percutaneous coronary intervention (PCI)...
  5. doi request reprint Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group
    Sunil V Rao
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 158:881-886.e1. 2009
    ..Clinical trials of antithrombotic agents for the treatment of ACS routinely assess bleeding as a safety endpoint, but variation in bleeding definitions makes comparison of the relative safety of these agents difficult...
  6. ncbi request reprint On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])
    Sunil V Rao
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 97:1478-81. 2006
    ..Randomized clinical trials are needed to confirm the efficacy of DESs in these clinical and angiographic settings. These data also highlight the importance of multicenter registries in tracking new technologies...
  7. ncbi request reprint Clinical outcomes with drug-eluting stents following atheroablation therapies
    Sunil V Rao
    Durham Veterans Affairs Medical Center and the Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    J Invasive Cardiol 18:393-6. 2006
    ..Because these techniques are still required in a minority of patients, we hypothesized that the use of drug-eluting stents (DES) would minimize the rate of major adverse cardiac events (MACE) after atheroablation...
  8. doi request reprint Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients
    Sunil V Rao
    Duke Clinical Research Institute, 508 Fulton St, Durham, North Carolina, USA
    JAMA 306:1461-7. 2011
    ..Patients undergoing elective percutaneous coronary intervention (PCI) are generally observed overnight in the hospital. The association between same-day discharge of older patients and death or readmission is unclear...
  9. doi request reprint Strategies to reduce bleeding among patients with ischemic heart disease treated with antiplatelet therapies
    Sunil V Rao
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Am J Cardiol 104:60C-3C. 2009
    ....
  10. ncbi request reprint Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, NC, USA
    Eur Heart J 28:1193-204. 2007
    ..Future directions for research and clinical practice are also discussed...
  11. doi request reprint The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, NC, USA
    J Am Coll Cardiol 55:2187-95. 2010
    ..Finally, we describe potential directions for future investigation in the transradial realm...
  12. doi request reprint Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, North Carolina, USA
    JACC Cardiovasc Interv 1:379-86. 2008
    ..Our goal was to compare trends in the prevalence and outcomes of the radial and femoral approaches to percutaneous coronary intervention (PCI) in contemporary clinical practice...
  13. ncbi request reprint International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 101:25-29. 2008
    ....
  14. doi request reprint Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial
    Sunil V Rao
    Duke Clinical Research Institute, Durham, NC, USA
    Circulation 121:1713-21. 2010
    ..We performed a phase 2 randomized trial to evaluate the safety and feasibility of M118 in the setting of elective percutaneous coronary intervention...
  15. doi request reprint Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 155:369-74. 2008
    ..We sought to determine the relationship between bleeding, blood transfusion, and measures of costs among patients with non-ST-segment elevation ACS...
  16. ncbi request reprint Patterns and outcomes of drug-eluting coronary stent use in clinical practice
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 152:321-6. 2006
    ..To determine patterns and outcomes of drug-eluting stents (DES) use in clinical practice...
  17. ncbi request reprint A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes
    Sunil V Rao
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 47:809-16. 2006
    ..The goal of this study was to determine the association between Thrombolysis In Myocardial Infarction (TIMI) and Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) bleeding and clinical outcomes...
  18. ncbi request reprint Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes
    Sunil V Rao
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Am J Cardiol 91:936-40. 2003
    ..This suggests that these patients should be admitted to the hospital and monitored in either an intensive care or step-down unit...
  19. ncbi request reprint Poverty, process of care, and outcome in acute coronary syndromes
    Sunil V Rao
    Duke Clinical Research Institute, dDuke University, PO Box 17969, Durham, NC 27715, USA
    J Am Coll Cardiol 41:1948-54. 2003
    ..We sought to determine whether income-based disparities in care processes and outcome exist in patients with acute coronary syndromes...
  20. ncbi request reprint Socioeconomic status and outcome following acute myocardial infarction in elderly patients
    Sunil V Rao
    Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27715, USA
    Arch Intern Med 164:1128-33. 2004
    ..Whether these disparities account for increased mortality among elderly poor patients is not known...
  21. doi request reprint Postmarket evaluation of breakthrough technologies
    Sunil V Rao
    Duke Clinical Research Institute and Duke University Medical Center, Durham, NC 27705, USA
    Am Heart J 156:201-8. 2008
    ....
  22. ncbi request reprint Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes
    Sunil V Rao
    Duke Clinical Research Institute, Durham, NC 27715, USA
    JAMA 292:1555-62. 2004
    ..It is unclear if blood transfusion in anemic patients with acute coronary syndromes is associated with improved survival...
  23. ncbi request reprint Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes
    Sunil V Rao
    The Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 96:1200-6. 2005
    ..Therapies that minimize bleeding risk and maintain an anticoagulant effect may improve outcomes among patients who have ACS...
  24. doi request reprint Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort
    Monique L Anderson
    7022 N Pavilion DUMC, PO Box 17969, Durham, NC 27715, USA
    Circulation 126:2190-9. 2012
    ..Conflicting evidence exists on sex-based outcomes after coronary stenting...
  25. pmc Prognostic significance of bleeding location and severity among patients with acute coronary syndromes
    John P Vavalle
    Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    JACC Cardiovasc Interv 6:709-17. 2013
    ..This study sought to determine if there is an association between bleed location and clinical outcomes in acute coronary syndromes (ACS) patients...
  26. doi request reprint Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches
    Sumeet Subherwal
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 165:644-54, 654.e1. 2013
    ..We describe alternative statistical approaches for concurrent assessment of the safety and efficacy of antithrombotic therapies used to treat patients with NSTE ACS...
  27. doi request reprint Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy
    Rajendra H Mehta
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am J Med 124:48-57. 2011
    ....
  28. ncbi request reprint Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarction
    Trip J Meine
    Duke University Medical Center, Durham, North Carolina, USA
    Ann Intern Med 143:481-5. 2005
    ....
  29. doi request reprint Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding
    Tracy Y Wang
    Duke Clinical Research Institute, 2400 Pratt St, Room 0311, Terrace Level, Durham, NC 27705, USA
    Circulation 118:2139-45. 2008
    ..Although the mechanism underlying this association is unclear, a potential explanation is that withholding antiplatelet therapies long beyond resolution of the bleeding event may contribute to recurrent events...
  30. pmc The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction
    Renato D Lopes
    Duke Clinical Research Institute, Box 3850, 2400 Pratt Street, Room 0311, Terrace Level, Durham, NC 27705, USA
    Eur Heart J 33:2044-53. 2012
    ..Their association with long-term outcomes is less clear. This study examines mortality associated with in-hospital bleeding during NSTEMI over time intervals starting from hospital discharge and extending past 3 years...
  31. doi request reprint Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry
    Eric D Peterson
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 55:1923-32. 2010
    ..We sought to create contemporary models for predicting mortality risk following percutaneous coronary intervention (PCI)...
  32. doi request reprint Trends and predictors of length of stay after primary percutaneous coronary intervention: a report from the CathPCI registry
    Chee Tang Chin
    Duke Clinical Research Institute, Durham, NC, USA
    Am Heart J 162:1052-61. 2011
    ..The extent to which ST-segment elevation myocardial infarction patients are discharged early after primary percutaneous coronary intervention (PPCI) in current practice is unknown...
  33. doi request reprint Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women)
    Connie N Hess
    Duke Clinical Research Institute, Durham, NC
    Am Heart J 166:421-8. 2013
    ..Secondary end points include procedure duration, contrast volume, radiation dose, quality of life, and a composite of 30-day death, vascular complication, or unplanned revascularization...
  34. doi request reprint Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008
    J Matthew Brennan
    Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 59:648-54. 2012
    ..This study sought to assess percutaneous coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) stenosis in routine U.S. clinical practice...
  35. ncbi request reprint The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative
    Xin Yang
    Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 46:1490-5. 2005
    ....
  36. doi request reprint Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes
    Karen P Alexander
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 155:1047-53. 2008
    ..To describe the association between transfusion and outcomes as a function of nadir hematocrit (HCT) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS)...
  37. doi request reprint The impact of postrandomization crossover of therapy in acute coronary syndromes care
    Kenneth W Mahaffey
    Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Circ Cardiovasc Qual Outcomes 4:211-9. 2011
    ..Using SYNERGY as an example, we demonstrate the difficulty of evaluating the effect of postrandomization events in clinical trials and discuss possible methodology...
  38. ncbi request reprint Economic assessment of thrombocytopenia: CATCH Registry
    Eric L Eisenstein
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    J Med Syst 34:379-86. 2010
    ..001); and (group 3) (difference, $27,077; 95% CI, $22,901-$31,252; P<.001). However, in our adjusted model, longer lengths-of-stay and greater use of blood transfusions accounted for most incremental in-hospital cost differences...
  39. doi request reprint Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)
    J Matthew Brennan
    Department of Medicine, Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    JACC Cardiovasc Interv 6:790-9. 2013
    ..This study sought to update and validate a contemporary model for inpatient mortality following percutaneous coronary intervention (PCI), including variables indicating high clinical risk...
  40. doi request reprint Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)
    Matthew A Cavender
    Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 104:507-13. 2009
    ..These findings suggest the need for definitive studies to evaluate the utility of noninfarct-related artery PCI among patients with STEMI...
  41. doi request reprint Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation
    John P Vavalle
    The Duke Clinical Research Institute, Durham, NC, USA
    Adv Cardiol 47:125-40. 2012
    ..Understanding the risk of bleeding associated with antiplatelet agents is critical to developing strategies to mitigate this risk...
  42. doi request reprint Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry
    Sumeet Subherwal
    Duke Clinical Research Institute, Durham, NC 27705, USA
    J Am Coll Cardiol 59:1861-9. 2012
    ....
  43. doi request reprint Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb
    Rajendra H Mehta
    Duke Clinical Research Institute, Duke University Medical Center, Box 17969, Durham, NC 27715, USA
    Eur Heart J 29:880-7. 2008
    ....
  44. ncbi request reprint State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction
    Manesh R Patel
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 44:192-8. 2004
    ..The purpose of this study was to determine whether state-mandated continuing medical education (CME) requirements affect the use of evidence-based therapies and outcomes in patients with acute myocardial infarction (AMI)...
  45. pmc TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium
    Connie N Hess
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 165:344-53.e1. 2013
    ..This article summarizes the content and proceedings of these sessions...
  46. doi request reprint Bivalirudin: a review of the pharmacology and clinical application
    David A Van De Car
    Duke University Medical Center, Division of Cardiology, 2301 Erwin Road, Durham, NC, USA
    Expert Rev Cardiovasc Ther 8:1673-81. 2010
    ..Additional agents in the class of direct thrombin inhibitors are under investigation and may find increasing clinical use...
  47. doi request reprint Association of bleeding and in-hospital mortality in black and white patients with st-segment-elevation myocardial infarction receiving reperfusion
    Rajendra H Mehta
    Duke Clinical Research Institute, Box 17969, Durham, NC 27715, USA
    Circulation 125:1727-34. 2012
    ..Additionally, it is unknown whether there are racial differences in bleeding risks among patients with ST-segment-elevation myocardial infarction receiving primary percutaneous coronary intervention...
  48. doi request reprint Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous
    Sergio Leonardi
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Am Heart J 160:65-72. 2010
    ..The INNOVATE-PCI study is a phase 2 randomized, double-blind, clopidogrel-controlled trial to evaluate the safety, tolerability, and preliminary efficacy of this novel antiplatelet agent in patients undergoing nonurgent PCI...
  49. ncbi request reprint Implications of bleeding and blood transfusion in percutaneous coronary intervention
    Sunil V Rao
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Rev Cardiovasc Med 8:S18-26. 2007
    ..Using strategies such as careful vascular access, alternative radial artery access, and modified antithrombotic regimen may reduce bleeding during PCI as well as improve patient outcomes...
  50. doi request reprint Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trial
    Chiara Melloni
    Duke Clinical Research Institute, Durham, NC, USA
    Am Heart J 158:726-33. 2009
    ....
  51. pmc Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial
    Chiara Melloni
    Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 160:795-803.e2. 2010
    ..Animal models of ischemia/reperfusion have demonstrated that single-dose erythropoietin may reduce infarct size, decrease apoptosis, and increase neovascularization, possibly through mobilization of endothelial progenitor cells...
  52. doi request reprint Long-term clinical outcomes following coronary stenting
    Kevin J Anstrom
    Department of Biostatistics, Duke Clinical Research Institute, Durham, NC 27715, USA
    Arch Intern Med 168:1647-55. 2008
    ..The objective of this study was to compare the long-term clinical outcomes of patients receiving DES vs BMS in a clinical practice setting...
  53. ncbi request reprint Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001
    David E Kandzari
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 143:217-28. 2002
  54. doi request reprint EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy
    Thomas J Povsic
    Duke Clinical Research Institute, Duke University Medical Center, Box 103208, Durham, NC, 27710, USA
    J Thromb Thrombolysis 36:375-83. 2013
    ..High-dose (≥30,000 U) EPO may mobilize EPCs at 48-72 h, and baseline EPC levels may be inversely associated with infarct size...
  55. ncbi request reprint Anemia in patients undergoing percutaneous coronary intervention: current issues and future directions
    Tracy Y Wang
    Duke University Medical Center, Durham VA Medical Center, Durham, North Carolina, USA
    Am J Cardiovasc Drugs 7:225-33. 2007
    ..In addition, we discuss alternative options for the management of anemia, such as the use of erythropoietin, aqueous oxygen, and hemoglobin-based oxygen carriers...
  56. ncbi request reprint Highlights from the American College of Cardiology Annual Scientific Sessions 2003: March 28 to April 2, 2003
    John L Petersen
    Duke Clinical Research Institute, Durham, NC, USA
    Am Heart J 146:19-26. 2003
  57. ncbi request reprint Bleeding as a predictor of mortality risk
    Sunil V Rao
    Durham VA Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA
    Rev Cardiovasc Med 7:S12-8. 2006
    ..Findings suggest that in the modern era of percutaneous coronary intervention, prevention of bleeding should be a goal of therapy, which can be achieved while preserving the low rate of ischemic complications...
  58. ncbi request reprint Major bleeding: management and risk reduction in acute coronary syndromes
    Matthew A Cavender
    Duke University Medical Center, Department of Medicine, Box 31110 Durham, NC 27710, USA
    Expert Opin Pharmacother 9:1869-83. 2008
    ..While this strategy reduces ischemic complications, it places patients at risk for bleeding complications...
  59. ncbi request reprint Device therapy in the management of congestive heart failure
    Aslan T Turer
    Department of Cardiology, Duke University, Durham, NC 27710, USA
    Cardiol Rev 13:130-8. 2005
    ....
  60. doi request reprint In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients: findings from the NCDR (National Cardiovascular Data Registry)
    Saeed Payvar
    East Carolina University Brody School of Medicine, Greenville, North Carolina, USA
    J Am Coll Cardiol 62:692-6. 2013
    ....
  61. ncbi request reprint The challenge of defining bleeding among patients with acute coronary syndromes
    Thomas W Wallace
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Clin Cardiol 30:II16-23. 2007
    ....
  62. doi request reprint Acute coronary syndromes: Blood transfusion in patients with acute MI and anaemia
    Matthew W Sherwood
    The Duke Clinical Research Institute, North Pavilion, 2400 Pratt Street, Durham, NC 27705, USA
    Nat Rev Cardiol 10:186-7. 2013
    ..These findings are consistent with previously published research, but clinical application of these data is hindered by the lack of prospective, randomized trials and the inherent bias in observational studies...
  63. pmc Association of systemic lupus erythematosus with angiographically defined coronary artery disease: a retrospective cohort study
    Mala S Kaul
    Duke University Medical Center, Durham, NC 27710, USA
    Arthritis Care Res (Hoboken) 65:266-73. 2013
    ..We compared the extent of angiographic abnormalities, CAD risk factors, and all-cause mortality in SLE patients with non-SLE controls...
  64. ncbi request reprint Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes
    Sharif A Halim
    Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
    Curr Drug Targets 12:1831-5. 2011
    ..This review describes the prevalence of bleeding during ACS management, risk for bleeding, and strategies to reduce bleeding risk...
  65. ncbi request reprint The association between the transradial approach for percutaneous coronary interventions and bleeding
    John P Vavalle
    Duke University Medical Center, Division of Cardiovascular Medicine, Durham, NC 27710 0001, USA
    J Invasive Cardiol 21:21A-24A. 2009
    ..Growing data to support the superior clinical outcomes with radial artery PCI, coupled with improved awareness of this data, may lead to increases in its adoption and improved clinical outcomes and mortality after PCI...
  66. doi request reprint Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes
    Antonio Gutierrez
    Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA
    Cleve Clin J Med 77:369-79. 2010
    ..The authors review the scope of the problem and ways to prevent and manage bleeding in this situation...
  67. ncbi request reprint Assessing quality in the cardiac catheterization laboratory
    Sunil V Rao
    Duke Clinical Research Institute, Durham NC 27710, USA
    Am Heart Hosp J 1:289-96. 2003
    ..Given the dynamic nature of cardiology, adaptable quality assurance and quality improvement programs will remain the foundation of successful catheterization labs...
  68. doi request reprint Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples
    Thomas J Povsic
    Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
    J Thromb Thrombolysis 28:259-65. 2009
    ....
  69. ncbi request reprint Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions
    Katie M Twomley
    Department of Medicine, Duke University Medical Center, Cardiovascular Thrombosis Center, Duke Clinical Research Institute, Durham, NC 27715, USA
    J Thromb Thrombolysis 21:167-74. 2006
    ....
  70. ncbi request reprint Highlights from the American Heart Association annual scientific sessions 2002: November 17 to 20, 2002
    Jean Pierre Dery
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 145:554-62. 2003
  71. ncbi request reprint Atrial fibrillation and percutaneous coronary intervention: stroke, thrombosis, and bleeding
    Antonio Gutierrez
    Department of Medicine, Duke University School of Medicine, DUMC 3850, Durham, NC, 27710, USA
    Curr Treat Options Cardiovasc Med 13:203-14. 2011
    ..Finally, as newer oral anticoagulation agents such as dabigatran and rivaroxaban become available, further research will be required to determine their safety and efficacy in patients with AF undergoing PCI with stenting...
  72. doi request reprint Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR)
    Tracy Y Wang
    J Am Coll Cardiol 51:2068-74. 2008
  73. doi request reprint The editor's roundtable: management and treatment of non-ST-segment elevation in acute coronary syndromes
    William C Roberts
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA
    Am J Cardiol 101:1580-98. 2008
  74. ncbi request reprint Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report
    Marc Cohen
    J Invasive Cardiol 18:617-39. 2006
    ..The addition of statins, ACE-inhibitors and beta-blockers is also stressed as part of a comprehensive secondary cardioprotective strategy for patients with coronary heart disease...
  75. ncbi request reprint Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III
    Marc Cohen
    Cardiac Cath Lab, 2nd Floor Bridge, Newark Beth Israel Medical Center, 201 Lyons Avenue, Newark, NJ, 07112, USA
    J Invasive Cardiol 19:525-38; quiz 539-40. 2007
    ..The addition of statins, angiotensin-converting enzyme (ACE) inhibitors and beta-blockers is also stressed as part of a comprehensive secondary cardioprotective strategy for patients with coronary heart disease...
  76. ncbi request reprint Association of race with complications and prognosis following acute coronary syndromes
    Craig R Asher
    Department of Cardiology, The Cleveland Clinic Foundation, Weston, Florida, USA
    Am J Cardiol 94:792-4. 2004
    ..The 1-year mortality rate was 2.9% for black patients and 2.5% for non-black patients (p = 0.93)...
  77. ncbi request reprint Erythropoietin, anemia, and orthostatic hypotension: the evidence mounts
    Sunil V Rao
    Clin Auton Res 12:141-3. 2002